Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Clin Cancer Res. 2018 Aug 21;25(1):73–79. doi: 10.1158/1078-0432.CCR-18-0110

Figure 1.

Figure 1.

Study schema for the safety run-in and efficacy study. Intention to treat analysis included all patients treated at the target dose (total N=81). RT = radiation therapy; Gy = gray; TMZ = temozolomide; IV = intravenous; DLT = dose limiting toxicity; MRI = magnetic resonance imaging.